bicalutamide polpharma 50 mg 50 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - bicalutamidum - tabletki powlekane - 50 mg
bicalutamide teva 50 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - bicalutamidum - tabletki powlekane - 50 mg
bicalutamida pentafarma 50 mg tabletki powlekane
pentafarma-sociedade tecnico-medicinal, s.a. - bicalutamidum - tabletki powlekane - 50 mg
bicalutamida pentafarma 150 mg tabletki powlekane
pentafarma-sociedade tecnico-medicinal, s.a. - bicalutamidum - tabletki powlekane - 150 mg
bicalutamide kabi 50 mg tabletki powlekane
fresenius kabi polska sp. z o.o. - bicalutamidum - tabletki powlekane - 50 mg
bikalutamid farmax 50 mg tabletki powlekane
svus pharma a.s. - bicalutamidum - tabletki powlekane - 50 mg
bikalutamid farmax 150 mg tabletki powlekane
svus pharma a.s. - bicalutamidum - tabletki powlekane - 150 mg
xtandi
astellas pharma europe b.v. - enzalutamid - nowotwory stercza - terapia endokrynologiczna - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
apo-flutam 250 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - flutamidum - tabletki powlekane - 250 mg
bicalutamide fair-med 50 mg tabletki powlekane
fair-med healthcare gmbh - bicalutamidum - tabletki powlekane - 50 mg